| CASE REPORT |
|
| Year : 2022 | Volume
: 4
| Issue : 1 | Page : 26 |
|
|
Unilateral acute anterior sclero-uveitis preceding Corona virus disease (COVID-19)
Srinivasan Sanjay, Ankush Kawali, Sameeksha Agrawal, Padmamalini Mahendradas
Department of Uveitis and Ocular Immunology, Narayana Nethralaya, Bengaluru 560010, Karnataka, India
Correspondence Address:
Srinivasan Sanjay
Department of Uveitis and Ocular Immunology, Narayana Nethralaya Super Speciality Hospital, Bengaluru, Karnataka
India
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/pajo.pajo_14_22
|
|
|
Coronavirus disease (COVID)-19 is associated with ophthalmic manifestations during and after recovery from the disease and may be sight-threatening. A 54-year-old Asian Indian female patient presented to us with redness, pain, and blurred vision in her right eye (RE) of 2-day duration. In RE, the best-corrected visual acuity was 20/25, and she was diagnosed with anterior sclero-uveitis. Three days later, she had mild breathlessness and loss of taste. Nasopharyngeal swab for reverse transcription–polymerase chain reaction-COVID-19 was positive, and investigations for uveitis were negative. The systemic evaluation was also within normal limits. A month later, she had no evidence of ocular inflammation. There was no other attributable cause to her ocular inflammation. Her COVID-19 immunoglobulin G antibody was positive, confirming the previous COVID-19 infection. The case emphasizes the importance for eye care professionals to remain vigilant and considers SARS-CoV-2 as the causative agent in patients presenting with anterior segment inflammation.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
